EARLY INTERVENTION REFERENCES

1.            Bonow, R.O., et al., ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in Collaboration With the Society of […]

EXAMINING THE COST BENEFIT OF EARLY INTERVENTION FOR SEVERE AORTIC STENOSIS

AORTIC STENOSIS IS UNDERTREATED DESPITE KNOWN CLINICAL BENEFITS The ACC/AHA Guideline mandated treatment for severe aortic stenosis (SAS) is aortic valve replacement (AVR)[1].   While over 67,000 AVRs are performed in America each year for aortic stenosis, population statistics estimate that over 500,000 people in America have severe aortic stenosis [2-4], illustrating that aortic stenosis is […]

What’s New in Structural Heart Disease Treatment?

Structural heart disease may be congenital (present from birth), may occur as a result of an infection in the heart (endocarditis), from damage during a heart attack (post-infarction), or because of heart valve disease that progresses with age(most commonly aortic stenosis or mitral regurgitation).  Heart valve problems such as valve leaking(regurgitation) and valve stiffening(stenosis), if […]

Untreated Aortic Stenosis Affecting Baby Boomer Generation at Alarming Rates

THE AGING POPULATION: “Baby Boomers” and Aortic Stenosis Aortic stenosis (AS) is the most common heart valve problem in the United States, affecting an estimated 3.4 million people in the United States.  As with many cardiovascular syndromes, the prevalence of aortic stenosis increases with age and it has been estimated that approximately 2% of people […]